Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MBRC-101 |
Trade Name | |
Synonyms | MBRC 101|MBRC101 |
Drug Descriptions |
MBRC-101 is an antibody-drug conjugate (ADC) comprising an anti-EphA5 monoclonal antibody linked to the anti-microtubule agent monomethyl auristatin E (MMAE), which potentially induces cytotoxicity against EPHA5-expressing tumor cells and inhibits tumor growth (Cancer Res (2024) 84 (6_Supplement): 738). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MBRC-101 | MBRC-101 | 0 | 1 |